Table 1. Narrow and comprehensive approaches to the economic evaluation of vaccines (14).
PerspectiveBenefit categories
Narrow and comprehensiveHealth care cost savings
Narrow and comprehensiveCare-related productivity gains
ComprehensiveOutcome-related productivity gains
ComprehensiveBehavior-related productivity gains
ComprehensiveCommunity externalities
ComprehensiveUtilitarian value of health gains